SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,264,000 | +30.8% | 11,060 | -21.7% | 0.00% | +100.0% |
| Q2 2019 | $966,000 | +87.6% | 14,134 | +102.4% | 0.00% | 0.0% |
| Q1 2019 | $515,000 | +3.4% | 6,982 | +13.7% | 0.00% | 0.0% |
| Q3 2018 | $498,000 | -5.7% | 6,142 | -39.1% | 0.00% | – |
| Q1 2018 | $528,000 | +0.8% | 10,084 | -11.7% | 0.00% | – |
| Q1 2014 | $524,000 | -4.4% | 11,426 | -16.8% | 0.00% | -100.0% |
| Q4 2013 | $548,000 | -8.8% | 13,730 | +0.8% | 0.00% | -25.0% |
| Q3 2013 | $601,000 | -15.1% | 13,624 | -39.6% | 0.00% | -33.3% |
| Q2 2013 | $708,000 | +227.8% | 22,545 | +143.2% | 0.01% | +200.0% |
| Q4 2012 | $216,000 | – | 9,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |